A Qsymia CardiovascuLAr morbIdity and Mortality (AQCLAIM) Study in Subjects with Documented Cardiovascular Disease
Latest Information Update: 19 Jul 2021
At a glance
- Drugs Phentermine/topiramate (Primary)
- Indications Cardiovascular disorders; Obesity
- Focus Therapeutic Use
- Acronyms AQCLAIM
- Sponsors PPD; VIVUS
- 17 Jul 2021 This trial has been discontinued in Czechia, according to European Clinical Trials Database record.
- 01 Jul 2021 This trial has been discontinued in Slovakia (End Date: 03 Aug 2015), according to European Clinical Trials Database record.
- 05 Sep 2014 New source identified and integrated (United Kingdom Clinical Research Network record:15440)